Zdrowie i gospodarka · 28/07/2011
FDA to Host Public Workshop on Clinical Outcome Assessments for New Drugs
The FDA is hosting a public workshop to gather input from patient advocates, healthcare providers, researchers, and regulators on the development and implementation of clinical outcome assessments for new drugs, with the goal of improving the evaluation of treatment benefits.
Source: Federal Register — Health and Human ServicesOpen original release →